Lupin Subsidiary LAHSA Enters Asset Purchase Agreement with Sanofi for Mature Products in Europe and Canada
Dec 22, 2023 17:12
CST Updated
17:12
Lupin
API and Generic Drug Manufacturers
Sanofi
Pharmaceutical R&D Developer
Lupin Atlantis Holdings
--
Lupin's Subsidiary LAHSA Announces Asset Purchase Agreement with Sanofi to Acquire a Series of Value-Added Mature Products in Europe and Canada (The Paper)Original Link